COMPARISON OF UPFRONT ARAT THERAPY AND CAB THERAPY FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER: A RETROSPECTIVE MULTICENTER STUDY

被引：0
|
作者：
Shiraishi, Yusuke
Tobe, Taisuke
Ueki, Hideto
Suzuki, Kotaro
Hara, Takuto
Terakawa, Tomoaki
Teishima, Jun
Nakano, Yuzo
Miyake, Hideaki
Fujisawa, Masato
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP60-10
引用
收藏
页码：E1003 / E1004
页数：2
相关论文
共 50 条
  • [1] Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study
    Okamoto, Teppei
    Noro, Daisuke
    Hatakeyama, Shingo
    Narita, Shintaro
    Mitsuzuka, Koji
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Hoshi, Senji
    Shimoda, Jiro
    Tanaka, Toshikazu
    Kawaguchi, Toshiaki
    Ishidoya, Shigeto
    Ito, Akihiro
    Tsuchiya, Norihiko
    Habuchi, Tomonori
    Ohyama, Chikara
    BMC CANCER, 2021, 21 (01)
  • [2] Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study
    Teppei Okamoto
    Daisuke Noro
    Shingo Hatakeyama
    Shintaro Narita
    Koji Mitsuzuka
    Toshihiko Sakurai
    Sadafumi Kawamura
    Senji Hoshi
    Jiro Shimoda
    Toshikazu Tanaka
    Toshiaki Kawaguchi
    Shigeto Ishidoya
    Akihiro Ito
    Norihiko Tsuchiya
    Tomonori Habuchi
    Chikara Ohyama
    BMC Cancer, 21
  • [3] Triple therapy in metastatic hormone-sensitive prostate cancer
    Tsaur, Igor
    Mirvald, Cristian
    Surcel, Cristian
    CURRENT OPINION IN UROLOGY, 2023, 33 (06) : 452 - 457
  • [4] Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Sweeney, Christopher J.
    Chen, Yu-Hui
    Carducci, Michael
    Liu, Glenn
    Jarrard, David F.
    Eisenberger, Mario
    Wong, Yu-Ning
    Hahn, Noah
    Kohli, Manish
    Cooney, Matthew M.
    Dreicer, Robert
    Vogelzang, Nicholas J.
    Picus, Joel
    Shevrin, Daniel
    Hussain, Maha
    Garcia, Jorge A.
    DiPaola, Robert S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 737 - 746
  • [5] Systemic therapy in metastatic hormone-sensitive prostate cancer
    McDonald, Jodie
    O'Brien, Jonathan
    Kostos, Louise
    Lawrentschuk, Nathan
    Azad, Arun A.
    Murphy, Declan
    Chen, Kenneth
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (04) : 234 - 239
  • [6] The optimal upfront therapy in metastatic hormone-sensitive prostate cancer: A network meta-analysis
    Mutlu, Hasan
    Bozcuk, Hakan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (02) : 394 - 402
  • [7] Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer
    Kelly, R.
    Wong, S. S. L.
    Shapiro, J.
    Weickhardt, A. J.
    Parente, P.
    Azad, A.
    Uccellini, A.
    Torres, J.
    Parnis, F.
    Kwan, E.
    Brown, S.
    Steer, C.
    Warren, M.
    Gibbs, P.
    Anton, A.
    Tran, B.
    ANNALS OF ONCOLOGY, 2022, 33 : S1498 - S1499
  • [8] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Mathieu, Romain
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2016, 69 (04) : 755 - 756
  • [9] Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer
    Hindie, Elif
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (22) : 3873 - 3875
  • [10] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Murphy, Declan G.
    Zargar, Homayoun
    EUROPEAN UROLOGY, 2016, 69 (03) : 540 - 540
12345